MedMira Announces Chief Financial Officer Transition

About this update from Medmira Inc.

[{"type":"text","content":"\n\n\nHALIFAX, July 11, 2014 /CNW/ - MedMira, Inc. (MedMira) (TSXV: MIR)\n announced today that Markus Meile has been appointed as the Company's\n Chief Financial Officer.  Effective immediately, Mr. Meile replaces\n Jelle Kuypers who has chosen to depart the Company.  Mr. Meile's\n proficiency in international finance, in addition to his experience in\n the medical device industry, makes him a valued member of the Company's\n executive leadership team as it drives MedMira's strategic initiatives\n forward.  Mr. Kuypers will assist with the transfer of the Company's\n financial leadership and day-to-day functions to Mr. Meile and his team\n during a defined transition period.\n\n\nMr. Meile has served as a member of MedMira's Board of Directors since\n 2010, was previously a member of its Audit Committee and, most\n recently, led the Company's business development activities as Senior\n Director, International Markets.  Effectively immediately, Mr. Meile\n will step down from the Board to move into his new role as Chief\n Financial Officer.\n\n\n\"On behalf of the Board and the management team, I would like to thank\n Mr. Kuypers for his contributions to MedMira and the support provided\n to the Company during this transition period. Mr. Kuypers has helped\n MedMira move to an enhanced financial foundation upon which our future\n success will be built,\" said Hermes Chan, CEO, MedMira Inc.\n\n\nPrior to joining MedMira, Mr. Meile worked with a number of financial\n institutions in Switzerland, England, and Hong Kong. Mr. Meile holds a\n BSc from Royal Holloway University of London and has studied business\n management, strategic planning, investment and accounting at business\n school in Zurich. Previously, Mr. Meile worked in the medical device\n industry in Africa, Asia Pacific, and Europe. Mr. Meile will combine\n his financial expertise with his broad range of international business\n knowledge to build financial and corporate strategies supporting\n MedMira's continuing growth and increasing shareholder value.\n\n\nMr. Meile's appointment as MedMira's Chief Financial Officer is subject\n to final approval of the TSX Venture Exchange.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of vertical flow rapid\n diagnostics. The Company's tests provide hospitals, labs, clinics and\n indi...

More updates from Medmira Inc.